Mortality is not associated with paclitaxel-coated devices usage in peripheral arterial disease of lower extremities
Abstract A recent meta-analysis addressed increased risk of death following revascularization with paclitaxel-coated devices in femopopliteal artery. We evaluated differences in all-cause mortality and amputation free survival between peripheral arterial disease (PAD) patients who were treated with...
Saved in:
Main Authors: | Dai Sik Ko, Gi Hwan Bae, Sang Tae Choi, Jaehun Jung, Jin Mo Kang |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/5385bb32fc7c46a18db1bdfa67fa9bbe |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Paclitaxel Exposure and Dosage of Drug-coated Devices for the Treatment of Femoropopliteal Peripheral Artery Disease
by: Ceazón T Edwards, et al.
Published: (2021) -
Study on the Lower Extremity Rehabilitation Device RHleg
by: Dao Minh Duc, et al.
Published: (2021) -
Paclitaxel- and Sirolimus-coated Balloons in Peripheral Artery Disease Treatment: Current Perspectives and Concerns
by: Masayuki Mori, et al.
Published: (2021) -
Combination of Exercise Testing Criteria to Diagnose Lower Extremity Peripheral Artery Disease
by: Olivier Stivalet, et al.
Published: (2021) -
Lower extremity MRI following 10-week supervised exercise intervention in patients with diabetic peripheral neuropathy
by: Nathan Davis, et al.
Published: (2021)